Literature DB >> 11985791

Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL).

Shin-ichi Nakatsuka1, Mieko Nishiu, Yasuhiko Tomita, Hideaki Miwa, Tetsuya Takakuwa, Keiji Iuchi, Satoru Yamamoto, Katsuyuki Aozasa.   

Abstract

Pyothorax-associated lymphoma (PAL) is a B-cell lymphoma of mostly large cell type developing in the pleural cavity of patients with long-standing pyothorax. Neuron-specific enolase (NSE) is an enolase comprising gamma subunit and is located at high levels in neuronal and neuroendocrine cells, together with their neoplasias. Expression of NSE at protein and mRNA levels was examined in PAL and other types (non-PAL) of non-Hodgkin's lymphomas. In PAL, serum levels of NSE were elevated (5.32 to 168.0, mean 42.6 ng/ml) and tended to decrease after incisional biopsy followed by chemotherapy (2.38 to 195.5, mean 34.1 ng/ml). Two cell lines established from two cases of PAL produced and secreted NSE in the culture medium. Immunohistochemistry revealed that the positive rate for NSE staining in PAL (10 of 14 cases, 71.4%) was significantly higher than that in non-PAL cases (6 of 38 cases, 15.8%) (P < 0.01). RT-PCR analysis showed that the expression levels of NSE mRNA in two cell lines and a biopsy sample from PAL were rather similar to those of the control samples from non-neoplastic lymph nodes. These findings suggest the posttranscriptional regulation of NSE in PAL. Thus, an elevation of serum NSE level in patients with chronic pyothorax may be an indicator of PAL development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985791      PMCID: PMC5927012          DOI: 10.1111/j.1349-7006.2002.tb01272.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

1.  Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.

Authors:  F R Nobels; D J Kwekkeboom; W Coopmans; C H Schoenmakers; J Lindemans; W W De Herder; E P Krenning; R Bouillon; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

2.  Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?

Authors:  W Ebert; R Ryll; T Muley; G Hug; P Drings
Journal:  Tumour Biol       Date:  1996

3.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

4.  Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties.

Authors:  C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1974-09-13

5.  Evaluation of gamma-enolase as a tumor marker for lung cancer.

Authors:  K Fujita; H Haimoto; M Imaizumi; T Abe; K Kato
Journal:  Cancer       Date:  1987-08-01       Impact factor: 6.860

6.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

7.  Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax.

Authors:  K Iuchi; A Ichimiya; A Akashi; T Mizuta; Y E Lee; H Tada; T Mori; K Sawamura; Y S Lee; K Furuse
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

8.  High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.

Authors:  Y Sasajima; H Yamabe; Y Kobashi; K Hirai; S Mori
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase.

Authors:  L Fletcher; C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1976-11-08

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  6 in total

1.  Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Authors:  Liang Wang; Panpan Liu; Xiaoqin Chen; Qirong Geng; Yue Lu
Journal:  Med Oncol       Date:  2011-08-30       Impact factor: 3.064

2.  Gamma-enolase predicts lung damage in severe acute pancreatitis-induced acute lung injury.

Authors:  Lawrence Owusu; Caiming Xu; Hailong Chen; Geliang Liu; Guixin Zhang; Jinwen Zhang; Zhankai Tang; Zhongwei Sun; Xin Yi
Journal:  J Mol Histol       Date:  2018-05-04       Impact factor: 2.611

3.  Primary diffuse large B-cell lymphoma of the chest wall: a case report.

Authors:  Xiaoming Qiu; Yi Liu; Yanjie Qiao; Gang Chen; Tao Shi; Jun Chen; Qinghua Zhou
Journal:  World J Surg Oncol       Date:  2014-04-22       Impact factor: 2.754

4.  A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Authors:  Rachel Polcyn; Jason God; Mollie Capone; Denise Matzelle; Naren L Banik; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2018-05-15

5.  Primary diffuse large B-cell lymphoma as a chest-wall mass: A case report.

Authors:  Qianwen Zhang; Yuanrong Ju; Tao Qu; Tao Wang; Xiaoqin Liu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Multifunctional neuron-specific enolase: its role in lung diseases.

Authors:  Cai-Ming Xu; Ya-Lan Luo; Shuai Li; Zhao-Xia Li; Liu Jiang; Gui-Xin Zhang; Lawrence Owusu; Hai-Long Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.